These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 3784240)
1. [Studies of serum rifampicin concentrations]. Takamoto M; Shinoda A; Kondou H; Nagano H; Kutsukake F; Mochizuki K; Taga Y; Yasutake T; Takano T; Hiro Y Kekkaku; 1986 Aug; 61(8):425-33. PubMed ID: 3784240 [No Abstract] [Full Text] [Related]
2. [Pyridoxine metabolism in pulmonary tuberculosis patients under rifampicin therapy in combination with isoniazid]. Baĭramaliev G; Krasheninnikova MA; Kolosovskaia VP; Chukanov VI Probl Tuberk; 1982 Jan; (1):58-62. PubMed ID: 7058194 [No Abstract] [Full Text] [Related]
3. [Initial pulmonary tuberculosis treated with the isoniazid-rifampicin combination and followed after cessation of treatment]. Oury M; Tuchais E; Viallet S; Chauvet G Rev Tuberc Pneumol (Paris); 1971 Dec; 35(8):819-28. PubMed ID: 5151119 [No Abstract] [Full Text] [Related]
4. Intermittent chemotherapy of pulmonary tuberculosis using rifampicin and isoniazid for primary treatment: the influence of various factors on the frequency of side-effects. Eule H; Werner E; Winsel K; Iwainsky H Tubercle; 1974 Mar; 55(1):81-9. PubMed ID: 4620295 [No Abstract] [Full Text] [Related]
5. [Place of ethambutol associated with isoniazid or with rifampicin in the treatment of pulmonary tuberculosis]. Lesobre R; Frey N Therapeutique; 1971 Apr; 47(4):387-90. PubMed ID: 5564051 [No Abstract] [Full Text] [Related]
6. [Results of initial treatment of pulmonary tuberculosis using ethambutol, isonicotinic acid hydrazide and rifampicin]. Kesztele V; Niederkofler J Wien Med Wochenschr; 1970 Jun; 120(25):473-5. PubMed ID: 5518004 [No Abstract] [Full Text] [Related]
7. A triple regimen of streptomycin, isoniazid and ethambutol or rifampicin, isoniazid and ethambutol in untreated cases of pulmonary tuberculosis. 3. Oka S; Sasaki M; Kobayashi T; Matsuda T Sci Rep Res Inst Tohoku Univ Med; 1972 Sep; 19(2):84-8. PubMed ID: 4649627 [No Abstract] [Full Text] [Related]
8. [Pharmacokinetics of rifampicin in patients with pulmonary tuberculosis]. Gol'dshteĭn VD; Ioffe RA; Kriukov VL Probl Tuberk; 1977 Apr; (4):61-6. PubMed ID: 877065 [No Abstract] [Full Text] [Related]
9. [Early results of sputum-positive patients with newly-detected pulmonary tuberculosis with rifampicin combined with isoniazid and SM (preliminary report)]. Ropek M; Szymański A; Banaszkiewicz H; Chetkowski A; Czaplińska-Jóźwiak E; Dabrowska-Solecka Z; Ignaczak J; Kondratowicz W; Królikowska H; Pawlik J; Pawlowska I; Sliwińska M; Szuster I; Szymánska W Gruzlica; 1973 Jul; 41(7):777-80. PubMed ID: 4730978 [No Abstract] [Full Text] [Related]
10. [Delayed results of treatment of pulmonary tuberculosis with rifampicin]. Fréour P; Bernadou M; Chomy P Gruzlica; 1974 May; 42(5):439-42. PubMed ID: 4464235 [No Abstract] [Full Text] [Related]
11. Serum concentration of isoniazid following administration of the drug alone and in combination with rifampicin in patients of pulmonary tuberculosis. Singhal KC; Rathi R; Kishore K; Varshney SC; Varshney DP Indian J Physiol Pharmacol; 1986; 30(1):115-7. PubMed ID: 3818028 [No Abstract] [Full Text] [Related]
12. [New anti-tubercular agents--rifampicin and ethambutol]. El'nik VI Klin Med (Mosk); 1971 May; 49(5):8-11. PubMed ID: 4946528 [No Abstract] [Full Text] [Related]
13. Controlled therapeutic trial with the combination rifampicin-isoniazid given for six months to previously untreated patients with pulmonary tuberculosis. Dubra F Bull Int Union Tuberc; 1972 Feb; 47():37-40. PubMed ID: 4562016 [No Abstract] [Full Text] [Related]
14. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 1. Comparison of rifampicin-ethambutol-isoniazid with streptomycin-paraminosalcylic acid-isoniazid in the original treatment of pulmonary tuberculosis patients]. Kekkaku; 1971 Oct; 46(10):393-9. PubMed ID: 5147895 [No Abstract] [Full Text] [Related]
15. [Usefulness of rifampicin for pulmonary resection of drug-resistant pulmonary tuberculosis--report of the 13th series study. C]. Kekkaku; 1973 Jan; 48(1):29-33. PubMed ID: 4632268 [No Abstract] [Full Text] [Related]
16. [Clinical trial of rifampicin as sole therapy. Study of serum levels]. Brouet G; Modaï J; Vergez P Rev Tuberc Pneumol (Paris); 1969; 33(1):27-42. PubMed ID: 5360580 [No Abstract] [Full Text] [Related]
17. [Treatment of pulmonary tuberculosis by combined rifampicin-isoniazid-streptomycin, and return to work after the 45th day]. Kreis B; Israël L; Pretet S Rev Tuberc Pneumol (Paris); 1969 Dec; 33(8):1091-108. PubMed ID: 5387445 [No Abstract] [Full Text] [Related]
18. On the pharmacokinetics of rifampicin I: Influence of dosage and duration of treatment with intermittent administration. Iwainsky H; Winsel K; Werner E; Eule H Scand J Respir Dis; 1974; 55(4):229-36. PubMed ID: 4438983 [No Abstract] [Full Text] [Related]
19. A cooperative study on rifampicin in original treatment of advanced pulmonary tuberculosis. Gyselen A; Verbist L; Cosemans J; Lacquet LM; Prignot J; Simon-Pouthier F; Debrabandere R; Devriendt J Acta Tuberc Pneumol Belg; 1969; 60(3):563-76. PubMed ID: 4906105 [No Abstract] [Full Text] [Related]
20. Intermittent chemotherapy of pulmonary tuberculosis using rifampicin and isoniazed for primary treatment: the influence of various factors on the frequency of side-effects. Eule H; Werner E; Winsel K; Iwainsky H Tubercle; 1974 Mar; 55(1):81-9. PubMed ID: 4470836 [No Abstract] [Full Text] [Related] [Next] [New Search]